Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

Clinical trial NCT07120464 · RECRUITING

Trial details

NCT number: NCT07120464
Sponsor: Liaoning Chengda Biotechnology CO., LTD
Status: RECRUITING
Study type: OBSERVATIONAL

Rabies Exposure Immunocompromised Chronic Disease

Start date: 2025-08-15
Primary completion: 2026-06-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.